![Dr. James Linder is CEO of Nebraska Medicine. (Courtesy of Nebraska Medicine)](https://media.eaglewebservices.com/public/2024/7/1721062298764.jpeg)
Aaron Sanderford
OMAHA — Nebraska Medicine’s board of directors this week chose Dr. James Linder, CEO of Nebraska Medicine, to replace new University of Nebraska President Dr. Jeffrey Gold as chair.
Linder has been CEO since 2018 and has helped teach at UNMC for four decades. He has served stints as interim president of NU and interim dean of the College of Medicine.
He is one of the NU Foundation’s lead fundraising chairs for its “Only in Nebraska” campaign. And he is known for his research on cervical cancer screening and work with blood disorders.
Gold left UNMC July 1 for NU’s Varner Hall after about a decade. Nebraska Medicine is UNMC’s decade-old nonprofit medical partner, operating hospitals and medical offices.
“Dr. Gold provided outstanding leadership since Nebraska Medicine was organized,” Linder said. “He can now bring transformative leadership to the University of Nebraska. “
Like many hospital groups, Nebraska Medicine is run by a group of people from local business, philanthropy, nonprofits and the medical community who essentially govern the system.
Mogens Bay, chair of Valmont Industries and vice chair of the Nebraska Medicine board, said, “It’s difficult to think of someone better suited to serve as board chair than Dr. Linder. He brings experience in leading clinical care, research and education,” plus years of work in business and giving.
Gold’s interim replacement at UNMC, Dr. H. Dele Davis, also joined the Nebraska Medicine board.